Abstract
We compared the performance of three 17α‐hydroxyprogesterone kits: the double antibody method, the coated tube method (ACTIVE™), both from Diagnostic Systems Laboratories, Inc. (DSL) and the coated tube method (COAT‐A‐COUNT®) from Diagnostic Products Corporation (DPC). The assay performance of the two DSL kits was very similar in terms of sensitivity, intra‐ and inter‐assay precision, linearity of dilution, recovery, and specificity. We also analyzed 190 samples for 17α‐hydroxyprogesterone values using the above three kits. Twenty‐three subjects were from prepubertal population (ages 1 month–13 years), thirty subjects were normal adult males (ages 20–53 years) and the remaining subjects were females in different phase of menstrual cycle (n = 40), on oral contraceptives (n = 20), post‐menopausal (n = 17), or pregnant women in their first, second, or third trimester (n = 60). In addition to these 60 pregnancy samples, we analyzed serial samples from 3 pregnancies. 17α‐OHP levels paralleled the progesterone levels in all three kits. Although there was reasonable correlation between the DPC and the two DSL kits, the 17α‐OHP values were found to be significantly higher with DPC kit during the 2nd and 3rd trimester of pregnancy indicating probable interference in the DPC assay by some structurally related steroids present during pregnancy. The DSL assays may be particularly well suited for measuring 17α‐OHP levels during pregnancy. J. Clin. Lab. Anal. 11:179–185, 1997. © 1997 Wiley‐Liss, Inc.
Keywords: 17α‐OH progesterone, progesterone, radioimmunoassay, normal values
References
- 1. Sippel WG, Dorr HG, Bidlingmaier F, Knorr D: Plasma levels of 17α‐hydroxyprogesterone, cortisol, and cortisone during infancy and childhood. Pediatr Res 1980; 14: 39–46. [DOI] [PubMed] [Google Scholar]
- 2. Lashansky G, Saenger P, Fishman K, Gautier T, Mayes D, Berg G, Di Martino‐Nardi J Reiter E: Normative data for adrenal steroidogenesis in a healthy pediatric population: age and sex‐related changes after adrenocorticotropin stimulation. J. Clin Endocrinol Metab 1991; 73: 674–686. [DOI] [PubMed] [Google Scholar]
- 3. Hughes IA, Winter JSD: The application of a serum 17OH‐progesterone radioimmunoassay to the diagnosis and management of congenital hyperplasia. J. Pediatr 1976; 88: 766–773. [DOI] [PubMed] [Google Scholar]
- 4. Petersen KE, Christensen T: 17‐hydroxyprogesterone in normal children and congenital adrenal hyperplasia. Acta Paediatr Scand 1979; 68: 205–211. [DOI] [PubMed] [Google Scholar]
- 5. Krieger DT: Rhythms of ACTH and corticosteroid secretion in health and disease and their experimental modification. J Steroid Biochem 1975; 6: 785–791. [DOI] [PubMed] [Google Scholar]
- 6. Thorneycroft IH, Mishell DR, Stone, SC , Kharma KM, Nakamura RM: The relation of serum 17‐hydroxyprogesterone and estradiol‐17β during the human menstrual cycle. Am J Obstet Gynecol 1971; 111: 947–951. [DOI] [PubMed] [Google Scholar]
- 7. Schoneshofer M, Wagner GG: Sex differences in corticosteroids in man. J Clin Endocrinol Metab 1977; 45: 814–817. [DOI] [PubMed] [Google Scholar]
- 8. New MI, Levine LS: Congenital Adrenal Hyperplasia. (Monographs on Endocrinology, vol. 26) Springer‐Verlag, Berlin: 1984. [PubMed] [Google Scholar]
- 9. New MI, DuPont B, Pang S, et al: An update on congenital adrenal hyperplasia. Recent Progress in Hormone Research 1981; 37: 105. [DOI] [PubMed] [Google Scholar]
- 10. Pang S, Hotchkiss J, Drash A, et al: Micro filter paper method for 17α‐hydroxyprogesterone radioimmunoassay: Its' application for rapid screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab 1977; 45: 1003. [DOI] [PubMed] [Google Scholar]
- 11. Riad‐Fahmy D, Read G, Hughes IA: Corticosteroids In: Gray CH, James VHT, eds. Hormones in blood. Volume 3, 3rd ed New York: Academic Press, 1979: 179–262. [Google Scholar]
- 12. Sawada J‐I, Terao T, Itoh S‐I, et al: Production and characterization of monoclonal antibodies to 17α‐hydroxyprogesterone. J Steroid Biochem 1987; 28: 405–10. [DOI] [PubMed] [Google Scholar]
- 13. Tsuji A, Maeda M, Arakawa H, et al: Fluorescence and chemiluminescence enzyme immunoassays of 17α‐hydroxyprogesterone in dried blood spotted on filter paper. J Steroid Biochem 1987; 27: 33–40. [DOI] [PubMed] [Google Scholar]
- 14. El‐Gamal BA, Eremin SA, Smith DS, Landon J: Development of a direct fluoroimmunoassay for serum levels of 17‐hydroxyprogesterone. Ann Clin Biochem 1988; 25: 35–41. [DOI] [PubMed] [Google Scholar]
- 15. Wallace AM, Beastall GH, Cook B, et al: Neonatal screening for congenital adrenal hyperplasia: a programme based on a novel direct immunoassay for 17‐hydroxyprogesterone in blood spots. J Endocrinol 1986; 108: 299–308. [DOI] [PubMed] [Google Scholar]
- 16. Pang S, Murphey W, Levine LS, et al: A pilot newborn screening for congenital adrenal hyperplasia in Alaska. J Clin Endocrinol Metab 1982; 55: 413–20. [DOI] [PubMed] [Google Scholar]
- 17. Dyas J, Read GF, Guha‐Maulik T, Hughes IA, Riad‐Fahmy D: A rapid assay for 17αOH‐progesterone in plasma, saliva and amniotic fluid using a magnetisable solid‐phase antiserum. Ann Clin Biochem 1984; 21: 417–24. [DOI] [PubMed] [Google Scholar]
- 18. Nahoul K, Scholler R: Comparison of saliva and plasma 17α‐hydroxyprogesterone time‐course response to hCG administration in normal men. J Steroid Biochem 1987; 26: 251–7. [DOI] [PubMed] [Google Scholar]
- 19. Wheeler MJ. (Ed.): Steroid and thyroid hormones. (The Immunoassay Kit Directory, Vol. 3, Part 2, pp 624–635). Kluwer Academic Publishers, 1994. [Google Scholar]
- 20. Tulchinsky D, Hobel CJ, Yeager F, Marshall JR: Plasma estrone, estradiol, estriol, progesterone, and 17α‐hydroxyprogesterone in human pregnancy‐normal pregnancy. Am J Obstet Gynecol 1972; 112: 1095–1100. [DOI] [PubMed] [Google Scholar]
- 21. Makela SK, Ellis G: Nonspecificity of a direct 17α‐hydroxyprogesterone radioimmunoassay kit when used with samples from neonates. Clin Chem 1988; 34: 2070–75. [PubMed] [Google Scholar]